Ahu PAKDEMİRLİ, Hülya ELLİDOKUZ, Yasemin BAŞBINAR, Aslıhan KARADAĞ, Hüseyin Koray MISIRLIOĞLU, Feriha TOKSÖZ, Osman AÇIKGÖZ

Role of mesenchymal stem cell-derived soluble factors and folic acid in wound healing

Background/aim: Mesenchymal stem cells (MSCs) are a type of adult stem cell consisting of a heterogeneous subset of stromal stemcells that can be isolated from adult tissues. Folic acid is another important contributor to tissue regeneration and repair, which affectsthe synthesis of some building block molecules used for wound healing. In this study, we examine the effect of folic acid and MSCderived soluble factors in the wound healing model.Materials and methods: Human umbilical vein endothelial cells (HUVECs) and bone marrow-derived MSCs (BMSCs) were culturedfor this study. Cell proliferation analysis was done with xCELLigence RTCA. After 48 h of cultivation, the cell culture medium wascollected as MSC conditional medium containing mesenchymal stem cell-derived soluble factors (MDFs). Different concentrations ofMDFs (12%, 25%, 50%, 75%, and 100%) were applied to the HUVEC cell line. Folic acid (25, 30, 50, 60, 75, 90, and 100 µM) was testedby application of three different groups (control, 25 µM folic acid, 625 µM folic acid inhibitors) for proliferation on the HUVEC cell line.The combined effects of folic acid and MDFs were tested on the HUVEC cell line with 25 µM folic acid and 50 µM MDFs. All data werestatistically analyzed using SPSS 15.0 for Windows.Results: Significant differences were observed between controls and cells treated with folic acid, as well as between controls and bothfolic acid and MDFs (P < 0.05). Among the treated groups, the fastest wound closure rate was seen in cells treated with both folic acidand MDFs.Conclusion: The results show that both folic acid and MDFs increased the wound healing rate in HUVECs when they were used separately. The strongest benefits were seen in treatment using folic acid and MDFs together.

PDF

___

1. Hu MS, Maan ZN, Wu JC, Rennert RC, Hong WX et al. Tissue engineering and regenerative repair in wound healing. Annals of Biomedical Engineering 2014; 42: 1494-1507. doi: 10.1007/ s10439-014-1010-z
2. Tang YH. Mesenchymal stem cell therapy in skin wound healing. Journal of Trauma and Acute Care Surgery 2016; 1: 2. doi: 10.21767/2476-2105.100002.
3. Aydemir I, Öztürk Ş, Kılıçaslan Sönmez P, Tuğlu Mİ. Mesenchymal stem cells in skin wound healing. Anatomy 2016; 10 (3): 228-234. doi: 10.2399/ana.16.043
4. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313. doi: 10.1016/j. stem.2008.07.003
5. Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells-current trends and future prospective. Bioscience Reports 2015; 2: 35. doi: 10.1042/BSR20150025
6. Jiao F, Wang J, Dong ZL, Wu MJ, Zhao TB et al. Human mesenchymal stem cells derived from limb bud can differentiate into all three embryonic germ layers lineages. Cellular Reprogramming 2012; 14: 324-333. doi: 10.1089/cell.2012.0004.
7. Kumar S, Wong PF, Leaper DJ. What is new in wound healing? Turkish Journal of Medical Sciences 2004; 34: 147–160.
8. Li XH, Yu XY, Lin QX, Deng CY, Shan ZX et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. Journal of Molecular and Cellular Cardiology 2007; 42: 295-303. doi: 10.1016/j. yjmcc.2006.07.002
9. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circulation Research 2011; 109 (8): 923-940. doi: 10.1161/CIRCRESAHA.111.243147
10. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. Journal of Cellular Physiology 2007; 21: 27. doi: 10.1002/jcp.20959
11. Volarevic V, Gazdic M, Simovic Markovic B, Jovicic N, Djonov V et al. Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential. Biofactors 2017; 43 (5): 633-644. doi: 10.1002/biof.1374
12. Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA et al. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998; 97 (3): 237-241.
13. Hoch AZ, Papanek P, Szabo A, Widlansky ME, Gutterman DD. Folic acid supplementation improves vascular function in professional dancers with endothelial dysfunction. PM&R 2011; 3 (11): 1005-1012. doi: 10.1016/j.pmrj.2011.02.014
14. Chen Z, Lin S. Folic acid in combination with adult neural stem cells for the treatment of spinal cord injury in rats. International Journal of Clinical and Experimental Medicine 2015; 8 (7): 10471-10480.
15. Maitreyee H, Robert MW Jr, Brian PB, Yong-Cheng W, Doo YLH et al. Pemetrexed in malignant pleural mesothelioma. Clinical Cancer Research 2005; 11: 982-992.
16. Krawczyk WS. A pattern of epidermal cell migration during wound healing. Journal of Cell Biology 1971; 49 (2): 247. doi: 10.1083/jcb.49.2.247
17. Duthie SJ, HawdonA. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB Journal 1998; 12: 1491-1497. doi: 10.1096/fasebj.12.14.1491
18. Chen L, Tredget EE, Wu PYG, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008; 3 (4): e1886. doi: 10.1371/journal.pone.0001886
19. Heseker H. Folic acid and other potential measures in the prevention of neural tube defects. Annals of Nutrition & Metabolism 2011; 59: 41-45. doi: 10.1159/000332126